GlassScriptPhysician profile
Bradley Ross
NPI 1588629455
$1,721.10
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,290 · 2020: $190 · 2021: $134 · 2022: $107.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $271.32 | 2019 | |
| Smith+Nephew, INC. | $225.08 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $122.69 | 2019-2020 | |
| Royal Biologics, INC. | $119.39 | 2019 | |
| Boston Scientific Corporation | $116.04 | 2019 | |
| Angiodynamics, INC. | $107.22 | 2022 | |
| Tactile Systems Technology INC | $106.42 | 2019 | |
| Organogenesis INC. | $101.51 | 2019 | |
| Comsort, INC | $100.00 | 2019 | |
| Orthofix Medical, INC. | $84.20 | 2019 | |
| Clarus Therapeutics INC. | $77.70 | 2021 | |
| Osiris Therapeutics INC. | $77.00 | 2019 | |
| Horizon Therapeutics Plc | $45.58 | 2019-2020 | |
| Melinta Therapeutics, LLC | $43.25 | 2019 | |
| Vertical Pharmaceuticals, LLC | $23.29 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seaspine Orthopedics Corporation | $21.85 | 2019 | |
| Antares Pharma, INC. | $21.25 | 2021 | |
| Abbvie INC. | $20.14 | 2021 | |
| Bioventus LLC | $16.32 | 2019 | |
| Lilly USA, LLC | $15.17 | 2021 | |
| Cardiovascular Systems INC. | $5.68 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.